GR3023251T3 - cDNA sequence and detection of hepatits C virus - Google Patents

cDNA sequence and detection of hepatits C virus

Info

Publication number
GR3023251T3
GR3023251T3 GR970400916T GR970400916T GR3023251T3 GR 3023251 T3 GR3023251 T3 GR 3023251T3 GR 970400916 T GR970400916 T GR 970400916T GR 970400916 T GR970400916 T GR 970400916T GR 3023251 T3 GR3023251 T3 GR 3023251T3
Authority
GR
Greece
Prior art keywords
virus
detection
hepatitis
hepatits
cdna sequence
Prior art date
Application number
GR970400916T
Other languages
English (en)
Inventor
Takenobu Kamada
Norio Hayashi
Eiji Mita
Keiji Ueda
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP41217790A external-priority patent/JPH04218376A/ja
Priority claimed from JP2936491A external-priority patent/JPH04218377A/ja
Priority claimed from JP4285591A external-priority patent/JPH04262784A/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of GR3023251T3 publication Critical patent/GR3023251T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR970400916T 1990-07-11 1997-04-22 cDNA sequence and detection of hepatits C virus GR3023251T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP18351290 1990-07-11
JP41217790A JPH04218376A (ja) 1990-12-18 1990-12-18 Ｃ型肝炎ウィルスのｃＤＮＡ配列
JP2936491A JPH04218377A (ja) 1990-07-11 1991-01-30 Ｃ型肝炎ウイルスのｃＤＮＡ配列および検出方法
JP4285591A JPH04262784A (ja) 1991-02-14 1991-02-14 Ｃ型肝炎ウイルスのｃＤＮＡ配列および検出方法

Publications (1)

Publication Number Publication Date
GR3023251T3 true GR3023251T3 (en) 1997-07-30

Family

ID=27459049

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400916T GR3023251T3 (en) 1990-07-11 1997-04-22 cDNA sequence and detection of hepatits C virus

Country Status (6)

Country Link
EP (1) EP0469348B1 (el)
AT (1) ATE150086T1 (el)
DE (1) DE69125066T2 (el)
DK (1) DK0469348T3 (el)
ES (1) ES2100185T3 (el)
GR (1) GR3023251T3 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT69140A (en) * 1990-08-10 1995-08-28 Chiron Corp Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
EP0787807B1 (en) * 1991-08-27 2003-05-28 F. Hoffmann-La Roche Ag Primers and probes for hepatitis C detection
ES2044784B1 (es) * 1992-06-12 1994-09-01 Inia Procedimiento para la deteccion e identificacion de patogenos virales y subvirales.
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
ES2133529T3 (es) 1992-11-27 1999-09-16 Innogenetics Nv Procedimiento para tipificar aislamientos de hcv.
US5851759A (en) * 1996-04-19 1998-12-22 Chiron Corporation Heteroduplex tracking assay (HTA) for genotyping HCV
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
ES2596753T3 (es) 2003-08-29 2017-01-11 Fujirebio Europe N.V. Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02500880A (ja) * 1987-11-18 1990-03-29 カイロン　コーポレイション Ｎａｎｂｖの診断用薬およびワクチン
JP2656995B2 (ja) * 1989-03-17 1997-09-24 カイロン コーポレイション Ｎａｎｂｖの診断用薬
RO113059B1 (ro) * 1989-05-18 1998-03-30 Chiron Corp Polinucleotida capabila de hibridizare pe o secventa hcv, metoda pentru detectarea unei secvente hcv si procedeu de eliminare a hcv din sange
CA2065287C (en) * 1989-09-15 1999-12-21 Tatsuo Miyamura New hcv isolates

Also Published As

Publication number Publication date
ES2100185T3 (es) 1997-06-16
EP0469348A3 (en) 1992-02-12
DE69125066T2 (de) 1997-09-25
EP0469348B1 (en) 1997-03-12
DK0469348T3 (da) 1997-04-01
ATE150086T1 (de) 1997-03-15
EP0469348A2 (en) 1992-02-05
DE69125066D1 (de) 1997-04-17

Similar Documents

Publication Publication Date Title
ATE231557T1 (de) Detektion des hepatis-c virus.
DK0935660T3 (da) Infektiöse kloner af RNA-virusser og vacciner og deraf afledte diagnostiske assays
ATE553201T1 (de) Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismittel
DK0992580T3 (da) Epitoper på human T-celler, som er immundominante for hepatitis C-virus
WO1993000365A3 (en) Hepatitis c virus (hcv) polypeptides
EP0484787A3 (en) Hcv-specific peptides, process for obtaining them and their use
DE68903165D1 (de) Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.
ATE17320T1 (de) Impfstoff, therapie gegen nicht-a nicht-b virale hepatitis und verfahren zur herstellung desselben.
DK158475C (da) Fremgangsmaade til fremstilling af interferon eller en interferonoploesning fra interferonproducerende bakterier.
EP0071640A4 (en) NOT-A, NOT-B HEPATITISVIRUS.
GR3023251T3 (en) cDNA sequence and detection of hepatits C virus
ES8403319A1 (es) Nuevas vacunas contra la bronquitis infecciosa.
PH31116A (en) Methods for the treatment of infection caused by hepatitis B virus (hbv).
DE3667960D1 (de) Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung.
DK498387A (da) Virus-dna-sekvens
EP0516859A4 (el)
WO1997040166A3 (en) Simian-human hav having a chimeric 2c protein
AU8277582A (en) Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing them